Roche Holding, a Drug developer and drug manufacturer, completed the acquisition of Obi Medical, a software developer. Financial terms were not disclosed. “In an emergency situation such as the Covid-19 pandemic, Roche v-TAC could also help healthcare professionals to assess disease severity faster in patients and closely monitor potential deterioration in patients with respiratory compromise. Digital tools based on clinical algorithms like Roche v-TAC can help improve and simplify delivery of care in emergency situations faster and where it is most needed,” Thomas Schinecker, Roche Diagnostics CEO.